Global Automated Insulin Delivery (AID) Market: Impact Analysis of COVID-19 (2020-2024)

DELHI, India - July 22, 2020 - PRLog -- The report titled "Global Automated Insulin Delivery (AID) Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)", provides an in-depth analysis of the global automated insulin delivery (AID) market with description of market sizing and growth. Furthermore, the report also provides detailed analysis of market by value, by device, by diabetes, by end user and by region.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and would be driving the growth of the industry. Growth of the overall global automated insulin delivery (AID) market has also been forecasted for the years 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.


Region Coverage

Asia Pacific
North America
Europe
Latin America
Middle East & Africa

Company Coverage

Medtronic Plc
Eli Lilly and Company
Novo Nordisk
Biocon

Executive Summary

Automated insulin delivery (AID) is also known as hybrid or full closed loop, artificial pancreas system (APS), looping, etc. Automated insulin delivery (AID) is a method for managing diabetes but it is not same for every patient. Patients have choices, ranging from the type of insulin pump and continuous glucose monitor (CGM) patient want to use. In addition, the technology has advanced the regulation of blood glucose concentrations, minimized the frequency of hyperglycaemic and improved the quality of life of people with diabetes.

There are different algorithms which are proposed for artificial pancreas system, which includes proportional integral derivative (PID) algorithms, model predictive control (MPC) algorithms and fuzzy logic algorithms.

Moreover, on the basis of devices automated insulin delivery (AID) can be segmented into hybrid closed loop and fully closed loop devices, whereas on the basis of end user automated insulin delivery (AID) can be bifurcated into hospital, retail medical store, health center and other.

The global automated insulin delivery (AID) market has progressed promptly over the years and the market is further anticipated to escalate during the forecasted years 2020 to 2024. The market would augment owing to numerous growth drivers such as, increasing diabetic population, growth in geriatric population, rising global healthcare expenditure, surging obese population, change in lifestyle of people globally, etc.


For further details, kindly visit :

https://www.daedal-research.com/pharma-healthcare/global-automated-insulin-delivery-aid-market-size-forecast-with-impact-analysis-of-covid-19-2020-2024

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-9811715635

Tel: +91-120-4553017

Mail ID - info@daedal-research.com